Technical and diagnostic performance of five commercial anti-diphtheria toxoid IgG enzyme-linked immunosorbent assay kits

Clinical and Vaccine Immunology

Volumn 17, Issue 10, 2010, Pages 1612-1616

  Faruq, A ^a   Dadson, L ^a   Cox, H ^a   Alcock, F ^a   Parker, A R ^a  

^a Binding Site Group Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA VACCINE; DIPTHERIA TOXOID IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, BACTERIAL; ANTITOXINS; BACTERIOLOGICAL TECHNIQUES; DIPHTHERIA; DIPHTHERIA TOXOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; SENSITIVITY AND SPECIFICITY;

EID: 77957870066     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00077-10     Document Type: Article

References (32)

1. Bonetti, T. C., R. C. Succi, L. Y. Weckx, L. Tavares-Lopes, and M. I. de Moraes-Pinto. 2004. Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine 22:3707-3712.
2. Bonilla, F. A., I. L. Bernstein, D. A. Khan, Z. K. Ballas, J. Chinen, M. M. Frank, L. J. Kobrynski, A. I. Levinson, B. Mazer, R. P. Nelson, Jr., J. S. Orange, J. M. Routes, W. T. Shearer, and R. U. Sorensen. 2005. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann. Allergy Asthma Immunol. 94:S1-S63.
3. Bracco Neto, H., A. Colucci, R. F. Puccini, and C. K. Farhat. 2005. Immunogenicity of a combined DTPa-HB vaccine co-administered with Haemophilus influenzae type B conjugate vaccine PRP-T for primary and booster vaccinations. Braz. J. Infect. Dis. 9:363-373.
4. Cellesi, C., A. Zanchi, C. Michelangeli, F. Giovannoni, A. Sansoni, and G. M. Rossolini. 1989. Immunity to diphtheria in a sample of adult population from central Italy. Vaccine 7:417-420.
5. de Vries, E. 2006. Patient-centered screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin. Exp. Immunol. 145:204-214.
6. Di Giovine, P., A. Pinto, R. M. Olander, D. Sesardic, P. Stickings, G. Berbers, S. Neal, A. Efstratiou, R. Paberza, S. Dauksiene, M. Bujko, A. Detcheva, U. Joks, B. Levent, and C. von Hunolstein. 2010. External quality assessment for the determination of diphtheria antitoxin in human serum. Clin. Vaccine Immunol. 17:1282-1290.
7. Edmunds, W. J., R. G. Pebody, H. Aggerback, S. Baron, G. Berbers, M. A. Conyn-van Spaendonck, H. O. Hallander, R. Olander, P. A. Maple, H. E. Melker, P. Olin, F. Fievret-Groyne, C. Rota, S. Salmaso, A. Tischer, C. von-Hunolstein, and E. Miller. 2000. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol. Infect. 125:113-125.
8. Galazka, A. M., and B. Kardymowicz. 1989. Immunity against diphtheria in adults in Poland. Epidemiol. Infect. 103:587-593.
9. Galazka, A. M., and S. E. Robertson. 1996. Immunization against diphtheria with special emphasis on immunization of adults. Vaccine 14:845-857.
10. Glenny, A. T., and M. Llewellyn-Jones. 1931. The intracutaneous method of testing diphtheria toxin and antitoxin. J. Pathol. Bacteriol. 34:143-156.
11. Goncalves, G., M. A. Santos, J. G. Frade, and J. S. Cunha. 2007. Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination. BMC Public Health 7:109.
12. Ipsen, J., Jr. 1954. Immunization of adults against diphtheria and tetanus. N. Engl. J. Med. 251:459-466.
13. Kimura, M., H. Kuno-Sakai, Y. Sato, H. Kamiya, R. Nii, S. Isomura, K. Horiuchi, T. Kato, M. Deguchi, and H. Saikusa. 1991. A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids. Outcome in 3- to 8-month-old infants, 9- to 23-month-old infants and children, and 24- to 30-month-old children. Am. J. Dis. Child. 145:734-741.
14. Knight, P. A., J. Tilleray, and J. Queminet. 1986. Studies on the correlation of a range of immunoassays for diphtheria antitoxin with the guinea-pig intradermal test. Dev. Biol. Stand. 64:25-32.
15. Maple, P. A., C. S. Jones, E. C. Wall, A. Vyseb, W. J. Edmunds, N. J. Andrews, and E. Miller. 2000. Immunity to diphtheria and tetanus in England and Wales. Vaccine 19:167-173.
16. McCusker, C., W. Somerville, V. Grey, and B. Mazer. 1997. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency. Ann. Allergy Asthma Immunol. 79:145-150.
17. Melville-Smith, M., and A. Balfour. 1988. Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test. J. Med. Microbiol. 25:279-283.
18. Middlebrook, J. L., R. B. Dorland, and S. H. Leppla. 1978. Association of diphtheria toxin with Vero cells. Demonstration of a receptor. J. Biol. Chem. 253:7325-7330.
19. Nordoy, T., A. Husebekk, I. S. Aaberge, P. A. Jenum, H. H. Samdal, L. B. Flugsrud, A. C. Kristoffersen, H. Holte, S. Kvaloy, and A. Kolstad. 2001. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant. 28:681-687.
20. Ramsay, M. E., M. J. Corbel, K. Redhead, L. A. Ashworth, and N. T. Begg. 1991. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. BMJ 302:1489-1491.
21. Robinson, M. J., C. Heal, E. Gardener, P. Powell, and D. G. Sims. 2004. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease. Pediatrics 113:733-737.
22. Sesardic, D., and M. J. Corbel. 1992. Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin. Lancet 340:737-738.
23. Skoura, L., A. Efstratiou, A. Tsakris, S. Pournaras, R. C. George, and J. Douboyas. 1999. Study on the use of an enzyme-linked immunosorbent assay in determining human antibodies to diphtheria toxin as compared with a reference toxin neutralization assay. Comp. Immunol. Microbiol. Infect. Dis. 22:181-186.
24. Smith, J. W. 1969. Diphtheria and tetanus toxoids. Br. Med. Bull. 25:177-182.
25. Tasman, A., and F. J. Huygen. 1962. Immunization against tetanus of patients given injections of antitetanus serum. Bull. World Health Organ. 26:397-407.
26. Theeten, H., H. Rumke, F. J. Hoppener, R. Vilatimo, S. Narejos, P. Van Damme, and B. Hoet. 2007. Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines. Curr. Med. Res. Opin. 23:2729-2739.
27. Van der Wielen, M., and P. Van Damme. 2000. Tetanus-diphtheria booster in non-responding tetanus-diphtheria vaccinees. Vaccine 19:1005-1006.
28. Vellinga, A., P. Van Damme, E. Joossens, and H. Goossens. 2000. Response to diphtheria booster vaccination in healthy adults: vaccine trial. BMJ 320:217. (Pubitemid 30175736)
29. Vitek, C. R., and M. Wharton. 1998. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg. Infect. Dis. 4:539-550.
30. Walory, J., P. Grzesiowski, and W. Hryniewicz. 2000. Comparison of four serological methods for the detection of diphtheria anti-toxin antibody. J. Immunol. Methods 245:55-65.
31. Wasserman, R. L., and R. U. Sorensen. 1999. Evaluating children with respiratory tract infections: the role of immunization with bacterial polysaccharide vaccine. Pediatr. Infect. Dis. J. 18:157-163.
32. Weckx, L. Y., K. Divino-Goes, D. M. Lihama, E. Carraro, N. Bellei, C. F. Granato, and M. I. Moraes-Pinto. 2006. Effect of a single tetanus-diphtheria vaccine dose on the immunity of elderly people in Sao Paulo, Brazil. Braz. J. Med. Biol. Res. 39:519-523.